129 related articles for article (PubMed ID: 37621061)
1. Correction to: Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma.
Br J Dermatol; 2023 Oct; 189(5):e79. PubMed ID: 37621061
[No Abstract] [Full Text] [Related]
2. Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma.
Van Laar R; Latif B; King S; Love C; Taubenheim N; Kalansooriya E; Wang W; Saad M; Winship I; Azzi A; Lilleyman A; Landgren T
Br J Dermatol; 2023 Aug; 189(3):292-301. PubMed ID: 37144735
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.
Huang SK; Hoon DS
Mol Oncol; 2016 Mar; 10(3):450-63. PubMed ID: 26778792
[TBL] [Abstract][Full Text] [Related]
4. A novel microRNA signature for the detection of melanoma by liquid biopsy.
Sabato C; Noviello TMR; Covre A; Coral S; Caruso FP; Besharat ZM; Splendiani E; Masuelli L; Battistelli C; Vacca A; Catanzaro G; Po A; Anichini A; Maio M; Ceccarelli M; Di Giacomo AM; Ferretti E
J Transl Med; 2022 Oct; 20(1):469. PubMed ID: 36243798
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-603 Promotes Progression of Cutaneous Melanoma by Regulating TBX5.
Dong X; Wang Y; Qu Y; Liu J; Feng X; Xu X
Comput Math Methods Med; 2021; 2021():1888501. PubMed ID: 35003317
[TBL] [Abstract][Full Text] [Related]
6. The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma.
Jiang L; Lv X; Li J; Li J; Li X; Li W; Li Y
Acta Histochem; 2012 Oct; 114(6):582-8. PubMed ID: 22130252
[TBL] [Abstract][Full Text] [Related]
7. Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives.
Kanemaru H; Mizukami Y; Kaneko A; Kajihara I; Fukushima S
Curr Treat Options Oncol; 2022 Apr; 23(4):562-577. PubMed ID: 35298769
[TBL] [Abstract][Full Text] [Related]
8. Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary.
Johansson I; Tempel D; Dwarkasing JT; Rentroia-Pacheco B; Mattsson J; Ny L; Olofsson Bagge R
Eur J Surg Oncol; 2022 Feb; 48(2):320-325. PubMed ID: 34794843
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Primary Cutaneous Melanoma.
Joyce D; Skitzki JJ
Surg Clin North Am; 2020 Feb; 100(1):61-70. PubMed ID: 31753116
[TBL] [Abstract][Full Text] [Related]
10. A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
Wada Y; Shimada M; Murano T; Takamaru H; Morine Y; Ikemoto T; Saito Y; Balaguer F; Bujanda L; Pellise M; Kato K; Saito Y; Ikematsu H; Goel A
Gastroenterology; 2021 Jul; 161(1):151-162.e1. PubMed ID: 33819484
[TBL] [Abstract][Full Text] [Related]
11. Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomas.
Jackett LA; Satgunaseelan L; Roper E; Lo SN; Thompson JF; Scolyer RA
Pathology; 2022 Feb; 54(1):71-78. PubMed ID: 34392983
[TBL] [Abstract][Full Text] [Related]
12. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
Lin N; Zhou Y; Lian X; Tu Y
Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
[TBL] [Abstract][Full Text] [Related]
13. Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
Łobaziewicz W; Szloch J; Wajda J; Legkiy O; Marczyk E; Wysocki W
Pol Przegl Chir; 2020 Mar; 92(3):15-21. PubMed ID: 32759393
[TBL] [Abstract][Full Text] [Related]
14. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
15. Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma.
Griffiths RW; Briggs JC
Ann R Coll Surg Engl; 1985 Mar; 67(2):75-8. PubMed ID: 3977262
[TBL] [Abstract][Full Text] [Related]
16. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
17. Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.
Marchetti MA; Dusza SW; Bartlett EK
JAMA Dermatol; 2022 Jun; 158(6):680-683. PubMed ID: 35475908
[TBL] [Abstract][Full Text] [Related]
18. Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint
Ziemer M; Weidenthaler-Barth B; Gussek P; Pfeiffer M; Kleemann J; Bankov K; Wild PJ; Seibold S; Sureshkumar P; Nickel P; Strobel A; Werner M; Grabbe S
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835839
[TBL] [Abstract][Full Text] [Related]
19. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.
Mariani G; Gipponi M; Moresco L; Villa G; Bartolomei M; Mazzarol G; Bagnara MC; Romanini A; Cafiero F; Paganelli G; Strauss HW
J Nucl Med; 2002 Jun; 43(6):811-27. PubMed ID: 12050328
[TBL] [Abstract][Full Text] [Related]
20. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression.
van Kempen LC; van den Hurk K; Lazar V; Michiels S; Winnepenninckx V; Stas M; Spatz A; van den Oord JJ
Virchows Arch; 2012 Oct; 461(4):441-8. PubMed ID: 22956368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
